Target intelligence / Profile preview

Coccidian parasite

Molecular classification
Other
01

Overview

Coccidian parasite refers to a broad group of microscopic, spore-forming, single-celled protozoan parasites that belong to the subclass Coccidia within the apicomplexan class Conoidasida. These obligate intracellular parasites infect the intestinal tracts of vertebrates and invertebrates, causing coccidiosis, a disease characterized by diarrhea, weight loss, and sometimes severe illness or death. Genera within Coccidia include Eimeria, Isospora, Toxoplasma, Sarcocystis, and Neospora, among others. Anticoccidial therapy targets various vital parasite proteins or enzymes, but "coccidian parasite" is not a single molecular target or receptor; instead, it is a broad taxonomic and pathological group[1][4][7][8]. Key clarification: - The entry "Coccidian parasite" is not a molecular target (e.g., receptor, enzyme, transporter). It is a collective organismal classification. Therefore, entries like canonical_abbreviation, biomarkers, and precise mechanism details are either not applicable or are variable between the many species and genera within Coccidia. - If a molecular therapeutic target within coccidia (e.g., a specific protein kinase, transporter, or enzyme) is of interest, a more specific query should be made (e.g., "Coccidian calcium-dependent protein kinase 1") for the structured data you described[5][6][9].

Other names
CoccidiaCoccidiasinacoccidiumapicomplexan coccidiaintestinal coccidia
02

Mechanism of action

Amprolium: thiamine antagonist, prevents parasite replication Decoquinate: inhibits mitochondrial electron transport Diclazuril, toltrazuril, ponazuril: alter parasite organelles and/or inhibit nuclear division[2][8] Ionophores: disrupt cation balance in parasite cells[8]

03

Biological functions

Infectionhost cell invasionintracellular survivaldisease causation
04

Disease associations

Infectionzoonosisanimal disease
05

Safety considerations

Development of drug resistanceadverse effects on host microbiotapotential toxicity with some treatments
06

Interacting drugs

Amprolium

6 more in the full profile.

Beyond the preview

Go deeper on Coccidian parasite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coccidian parasite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call